Astatine is the least abundant element on Earth, and all of its known isotopes have a half-life of less than 8 hours. One astatine isotope, astatine-211 (At-211), emits alpha particles and shows promise as a cancer therapy. ...
May 31, 2023
0
2
Some types of cancer and other diseases are treated with a drug containing radioactive material that targets the tumor. However, the drug can also be deposited in healthy organs, potentially damaging the kidneys, gut or bone ...
Aug 8, 2022
0
93
Cutting across demographic and geographic lines, cancer remains the second-leading cause of death in the United States. According to the National Cancer Institute, more than one in three men and women in America will be diagnosed ...
Aug 2, 2022
0
11
A research team from the Graduate School of Medicine at Osaka University has started an investigator-initiated clinical trial of sodium astatine ([211At]NaAt) injection for refractory differentiated thyroid cancer patients. ...
Nov 29, 2021
0
0
Preclinical trials of a new radiopharmaceutical to treat ovarian cancer have produced successful results, dramatically limiting tumor growth and decreasing tumor mass. Designed specifically for ovarian cancers that are resistant ...
Jun 11, 2021
0
2
Pancreatic cancer is one of the leading causes of cancer‑related deaths worldwide. Patients with pancreatic cancer often receive chemotherapy or radiation therapy, which are not always effective and can have toxic side ...
Oct 15, 2019
0
1
Prostate cancer patients with advanced tumors that have spread to bone have a poor chance of surviving. Patients with the disease may now live longer with a new line of radioisotope therapy, say researchers at the Society ...
Jun 11, 2012
0
0
Tobacco companies knew that cigarette smoke contained radioactive alpha particles for more than four decades and developed "deep and intimate" knowledge of these particles' cancer-causing potential, but they deliberately ...
Sep 28, 2011
10
0
Until recently, options for patients with bone metastases from advanced prostate cancer have been very limited. But now the first Phase III study of an alpha-pharmaceutical in these patients has shown that it can prolong ...
Sep 23, 2011
0
1
(Medical Xpress) -- Our liver could be a major springboard for determining life-changing diabetes diagnosis and treatment thanks to a world-first discovery by an Australian-Chinese research team.
Jun 15, 2011
0
0
